Clinical Review Letter

Nurse Practitioner PRIVATE AND CONFIDENTIAL Review Date: 01/11/2024 / Letter Date: 01/11/2024 Dr. Sarah Peterson Greenwood Medical Centre 123 Health Lane, Anytown, UK Dear Dr. Sarah Peterson, Re: Ms. Jane Doe DOB 05/03/1988 Attended: 01/11/2024 via video consultation Diagnosis: Generalised Anxiety Disorder (GAD) Current Medication: Sertraline 50mg once daily; Propranolol 10mg twice daily as needed for anxiety Physical Health Observations Blood Pressure (mmHg): 128/82 (01/11/2024) Pulse (bpm): 78 (01/11/2024) Weight (kg): 68 (01/11/2024) Height (cm): 165 (01/11/2024) BMI: 25.0 (01/11/2024) Reason For Appointment Ms. Jane Doe attended a follow-up video consultation with Nurse Practitioner Olivia Smith to review her current medication regimen for Generalised Anxiety Disorder and discuss recent fluctuations in her anxiety symptoms. Her husband, Mr. John Doe, was also present during the consultation. History Of Presenting Complaint Ms. Doe reports that her anxiety symptoms have been more prominent over the past two weeks, particularly manifesting as increased worry about her work performance and occasional panic-like sensations. She describes feeling restless and having difficulty concentrating. She notes that the Sertraline has generally been helpful in managing her baseline anxiety, but the recent stressors have led to a breakthrough of symptoms. She has been taking Propranolol as needed, which provides some relief for physical symptoms but does not address the underlying worry. There have been no changes to her medication dosage since the last review. She denies any specific triggers for the recent escalation, attributing it to general work-related stress. Mental State Examination Appearance And Behaviour: Ms. Doe appeared neatly dressed and maintained good eye contact throughout the consultation; she exhibited some fidgeting with her hands. Mood And Affect: Her mood was reported as anxious and restless, with an affect that was congruent with her mood, showing some tension. Speech: Speech was of normal rate and volume, clear, and coherent. Thought Content: Thought content revealed prominent themes of worry about future events, particularly related to work, and mild rumination; she denied any suicidal ideation, self-harm thoughts, or thoughts of harm to others. Cognition: Patient was oriented to time, place, and person; memory and concentration appeared intact during the interview. Insight And Judgement: Insight into her anxiety condition was good, acknowledging the need for continued management; her judgment appeared unimpaired. Risk Assessment Risk To Self: Low risk of self-harm or suicide; patient denies any active thoughts, plans, or intent, and has good social support from her husband. Risk To Others: Not assessed. Risk Of Self-Neglect: Not assessed. Risk From Others: Not assessed. Clinical Assessment Ms. Doe presents with an exacerbation of her Generalised Anxiety Disorder, likely triggered by recent occupational stressors. Her current medication regimen, while previously effective, appears insufficient to manage the increased symptom burden. There are no signs of psychotic symptoms or severe depression. Her coping mechanisms appear to be strained, leading to increased physical and emotional manifestations of anxiety. The patient demonstrates good insight and willingness to engage in further management strategies. Management Plan Medication: * Continue Sertraline 50mg once daily. * Increase Sertraline to 75mg once daily, to be reviewed in 4 weeks. Patient advised on potential side effects of dose increase. * Continue Propranolol 10mg twice daily as needed for somatic anxiety symptoms. * Advised to monitor for any adverse reactions to the medication increase. Therapeutic Interventions: * Refer for Cognitive Behavioural Therapy (CBT) to address anxiety management techniques and coping strategies. * Advised on relaxation techniques and mindfulness exercises. * Recommended exploring stress reduction strategies related to her work environment. Follow-Up Ms. Doe is scheduled for a follow-up review with Nurse Practitioner Olivia Smith in 4 weeks to assess the efficacy of the increased Sertraline dosage and discuss progress with CBT referral. The patient will be contacted by the practice administrative team regarding the CBT referral. Yours sincerely, Olivia Smith Nurse Practitioner City Medical Practice 020 7123 4567 CC: Dr. Eleanor Vance (GP)